Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level.

Abstract:

:Intravenously applied normal human immunoglobulin G (IgG) has anti-inflammatory effects in the treatment of autoimmune diseases. Systemic inflammation can originate from an overreacting amplification loop of the complement system. In blood, C3b2-containing complexes maintain complement amplification much better than the extremely short-lived C3b. Therefore, in patients with the complement-dependent autoimmune disease, dermatomyositis, we studied whether intravenously applied normal human IgG (IVIG) stimulated in vivo inactivation of these complexes. In the course of IVIG treatment, clinically effective in 6 of 8 patients, the concentration of C3b2-containing complexes dropped to 37% +/- 14% (n = 6) of the pretreatment level when having infused 0.5 g IgG/kg body weight, increased marginally and in parallel to factor Bb thereafter until full-dose IgG was infused. By day 14 following infusion of 2 g IgG/kg body weight the concentration of C3b2-containing complexes was 66% +/- 19%. The plasma concentration of C3 remained constant in myopathic or increased by 15% to 20% in amyopathic patients. In contrast to this, IVIG infusion was associated with consumption of up to 40% of plasma C4 at day 1 to 2 after completion of IVIG infusion. Thus, IVIG had an immediate and long-lasting attenuating effect on complement amplification in vivo, despite the fact that it induced classical complement pathway activation.

journal_name

Blood

journal_title

Blood

authors

Lutz HU,Stammler P,Bianchi V,Trüeb RM,Hunziker T,Burger R,Jelezarova E,Späth PJ

doi

10.1182/blood-2003-05-1530

subject

Has Abstract

pub_date

2004-01-15 00:00:00

pages

465-72

issue

2

eissn

0006-4971

issn

1528-0020

pii

2003-05-1530

journal_volume

103

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan.

    abstract::Because there is no known genetic abnormality common to all patients with myeloma, it is important to understand how genetic heterogeneity may lead to differences in signal transduction, cell cycle, and response to therapy. Model cell lines have been used to study the effect that mutations in p53 and ras can have on g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rowley M,Liu P,Van Ness B

    更新日期:2000-11-01 00:00:00

  • Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.

    abstract::Dosing of enzyme replacement therapy (ERT) for Gaucher disease type 1 is still a subject of debate and varies from 15 to 130 U/kg/mo, making a huge economic difference of 70,000 US dollars to 380,000 US dollars(euro55,000-300,000) per patient per year. To investigate whether this difference in dosing ultimately transl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2005-12-5072

    authors: de Fost M,Hollak CE,Groener JE,Aerts JM,Maas M,Poll LW,Wiersma MG,Häussinger D,Brett S,Brill N,vom Dahl S

    更新日期:2006-08-01 00:00:00

  • Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation.

    abstract::Expression of the myeloperoxidase (MPO) gene is tightly regulated in a tissue- and development-specific manner. Accumulation of MPO messenger RNA (mRNA) occurs only at the late myeloblastic and promyelocytic stages of myeloid differentiation and is negligible at other stages of myeloid development and in other tissues...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lübbert M,Miller CW,Koeffler HP

    更新日期:1991-07-15 00:00:00

  • Why "R" HIT patients predisposed to thrombosis?

    abstract::In this issue of Blood, Rollin et al demonstrate that heparin-induced thrombocytopenia and thrombosis (HIT) patients homozygous for arginine (R) at position 131 in the immunoglobulin (Ig)G receptor FcγRIIA have a significantly higher incidence of thrombosis, and show that plasma IgG may play a key role in modulating t...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-02-629782

    authors: Padmanabhan A

    更新日期:2015-04-09 00:00:00

  • Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells.

    abstract::Angiotensin I-converting enzyme (ACE) inhibitors can affect hematopoiesis by several mechanisms including inhibition of angiotensin II formation and increasing plasma concentrations of AcSDKP (acetyl-N-Ser-Asp-Lys-Pro), an ACE substrate and a negative regulator of hematopoiesis. We tested whether ACE inhibition could ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3828

    authors: Charrier S,Michaud A,Badaoui S,Giroux S,Ezan E,Sainteny F,Corvol P,Vainchenker W

    更新日期:2004-08-15 00:00:00

  • A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.

    abstract::Stat5 proteins are critical signaling molecules activated by many cytokines. Within the immune system, Stat5 plays important roles related to the development of thymocytes and proliferation of T cells. Stat5 has been implicated in malignant transformation, and moreover, the activated tyrosine phosphorylated form of St...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-084707

    authors: Bessette K,Lang ML,Fava RA,Grundy M,Heinen J,Horne L,Spolski R,Al-Shami A,Morse HC 3rd,Leonard WJ,Kelly JA

    更新日期:2008-01-01 00:00:00

  • X chromosome inactivation analysis reveals a difference in the biology of ET patients with JAK2 and CALR mutations.

    abstract::Calreticulin mutations (CALR(MUT)) are found in a significant proportion of patients with essential thrombocythemia (ET) lacking JAK2(V617F) or MPL mutations. They are associated with substantially different hematological and clinical features and define a distinct subtype of ET. We show here that their presence is si...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-06-580183

    authors: Allen C,Lambert JR,Linch DC,Gale RE

    更新日期:2014-09-25 00:00:00

  • Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.

    abstract::Follicular lymphoma (FL) is a low-grade B-cell non-Hodgkin's lymphoma (NHL) that frequently transforms into diffuse aggressive NHL. The majority of FLs display a t(14; 18) translocation that places the bcl-2 gene into juxtaposition with the lg heavy-chain (H) gene locus. Morphologically transformed malignant FL cells ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Matolcsy A,Casali P,Warnke RA,Knowles DM

    更新日期:1996-11-15 00:00:00

  • Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.

    abstract::Omenn syndrome (OS) is an inherited disorder characterized by an absence of circulating B cells and an infiltration of the skin and the intestine by activated oligoclonal T lymphocytes, indicating that a profound defect in the lymphoid developmental program could be accountable for this condition. Inherited mutations ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.9.2772

    authors: Corneo B,Moshous D,Güngör T,Wulffraat N,Philippet P,Le Deist FL,Fischer A,de Villartay JP

    更新日期:2001-05-01 00:00:00

  • Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.

    abstract::Fifty-one children with acute lymphoblastic leukemia (ALL) in second or subsequent remission after a first remission of at least 24 months underwent purged, autologous bone marrow transplantation (ABMT). Bone marrow was harvested in remission and purged in vitro with monoclonal antibodies specific for leukemia-associa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Billett AL,Kornmehl E,Tarbell NJ,Weinstein HJ,Gelber RD,Ritz J,Sallan SE

    更新日期:1993-03-15 00:00:00

  • Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

    abstract::Sickle cell disease (SCD) is characterized by a single point mutation in the seventh codon of the β-globin gene. Site-specific correction of the sickle mutation in hematopoietic stem cells would allow for permanent production of normal red blood cells. Using zinc-finger nucleases (ZFNs) designed to flank the sickle mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-12-615948

    authors: Hoban MD,Cost GJ,Mendel MC,Romero Z,Kaufman ML,Joglekar AV,Ho M,Lumaquin D,Gray D,Lill GR,Cooper AR,Urbinati F,Senadheera S,Zhu A,Liu PQ,Paschon DE,Zhang L,Rebar EJ,Wilber A,Wang X,Gregory PD,Holmes MC,Reik A

    更新日期:2015-04-23 00:00:00

  • Sialyl Lewis(x) (sLe(x)) and an sLe(x) mimetic, CGP69669A, disrupt E-selectin-dependent leukocyte rolling in vivo.

    abstract::Leukocyte rolling is the earliest observable even in their recruitment from the circulation to inflamed tissue. This rolling is mediated largely by interaction between the selectin family of adhesion molecules and their glycosylated ligands. Although the nature of these ligands and their interaction with the selectins...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Norman KE,Anderson GP,Kolb HC,Ley K,Ernst B

    更新日期:1998-01-15 00:00:00

  • CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.

    abstract::The chemokine receptors (CCRs) CCR4 and CCR10, and the cutaneous lymphocyte antigen (CLA), have each been proposed as critical mediators of skin-specific TH lymphocyte homing in mice and humans. CLA initiates skin homing by mediating E-selectin-dependent tethering and rolling within cutaneous venules, but the specific...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2348

    authors: Soler D,Humphreys TL,Spinola SM,Campbell JJ

    更新日期:2003-03-01 00:00:00

  • Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization.

    abstract::Twenty-four patients whose cells contained a variety of 11q23 rearrangements, including translocations, insertions, and an inversion, were studied using fluorescence in situ hybridization with cosmid, phage, and plasmid probes mapped to 11q22-24. In 17 patients, the breakpoints of the common 11q23 translocations invol...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kobayashi H,Espinosa R 3rd,Thirman MJ,Gill HJ,Fernald AA,Diaz MO,Le Beau MM,Rowley JD

    更新日期:1993-07-15 00:00:00

  • Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia.

    abstract::The model of erythroleukemia caused by Spi-1/PU.1 transgenesis in mice is a multistage disease. A preleukemic step is characterized by an acute proliferation of proerythroblasts due to the arrest of differentiation provoked by Spi-1/PU.1. Later on, a blastic crisis occurs associated with somatic oncogenic mutations in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-110510

    authors: Monni R,Haddaoui L,Naba A,Gallais I,Arpin M,Mayeux P,Moreau-Gachelin F

    更新日期:2008-03-15 00:00:00

  • Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.

    abstract::Graft-versus-host disease (GVHD) is driven by extensive activation and proliferation of alloreactive donor T cells causing significant morbidity and mortality following allogeneic hematopoietic cell transplantation (HCT). Invariant natural killer T (iNKT) cells are a potent immunoregulatory T-cell subset in both human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-11-612762

    authors: Schneidawind D,Baker J,Pierini A,Buechele C,Luong RH,Meyer EH,Negrin RS

    更新日期:2015-05-28 00:00:00

  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

    abstract::Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher complete and overall re...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-03-342485

    authors: Smith MR,Neuberg D,Flinn IW,Grever MR,Lazarus HM,Rowe JM,Dewald G,Bennett JM,Paietta EM,Byrd JC,Hussein MA,Appelbaum FR,Larson RA,Litzow MR,Tallman MS

    更新日期:2011-09-29 00:00:00

  • Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion.

    abstract::Insulin-like growth factor 1 (IGF-1) enhances thymopoiesis but given the broad distribution of IGF-1 receptors (IGF-1Rs), its mechanism of action has remained unclear. To identify points of thymic regulation by IGF-1, we examined its effects on T-cell precursors, thymocytes, and thymic epithelial cells (TECs) in norma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-149435

    authors: Chu YW,Schmitz S,Choudhury B,Telford W,Kapoor V,Garfield S,Howe D,Gress RE

    更新日期:2008-10-01 00:00:00

  • Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.

    abstract::Chronic transfusion of packed red blood cells, in addition to other ongoing treatment with warfarin, acetyl salicylic acid, desferrioxamine, and other supportive measures, was given to a splenectomized hemoglobin E/beta-thalassemia woman with pulmonary arterial hypertension (PHT). Serial measurements of plasma thrombi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-09-3094

    authors: Atichartakarn V,Chuncharunee S,Chandanamattha P,Likittanasombat K,Aryurachai K

    更新日期:2004-04-01 00:00:00

  • How I treat patients who mobilize hematopoietic stem cells poorly.

    abstract::Transplantation with 2-5 × 10(6) mobilized CD34(+)cells/kg body weight lowers transplantation costs and mortality. Mobilization is most commonly performed with recombinant human G-CSF with or without chemotherapy, but a proportion of patients/donors fail to mobilize sufficient cells. BM disease, prior treatment, and a...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-06-318220

    authors: To LB,Levesque JP,Herbert KE

    更新日期:2011-10-27 00:00:00

  • One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.

    abstract::No consensus exists on whether acyclovir prophylaxis should be given for varicella-zoster virus (VZV) prophylaxis after hematopoietic cell transplantation because of the concern of "rebound" VZV disease after discontinuation of prophylaxis. To determine whether rebound VZV disease is an important clinical problem and ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2007-03-077644

    authors: Erard V,Guthrie KA,Varley C,Heugel J,Wald A,Flowers ME,Corey L,Boeckh M

    更新日期:2007-10-15 00:00:00

  • Plasma cell myeloma--new biological insights and advances in therapy.

    abstract::Plasma cell myeloma is a more complex neoplasm than suggested by the relative uniformity of its dominant plasma cells, which represent the terminal stage of normal B-cell differentiation. Phenotypic, molecular, and cellular genetic data favor the presence of a myeloma stem cell early in hematopoietic development so th...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Barlogie B,Epstein J,Selvanayagam P,Alexanian R

    更新日期:1989-03-01 00:00:00

  • Duration of immunosuppressive treatment for chronic graft-versus-host disease.

    abstract::Chronic graft-versus-host disease (GVHD) requires long-term immunosuppressive therapy after hematopoietic cell transplantation. We retrospectively analyzed a cohort of 751 patients with chronic GVHD to identify characteristics associated with the duration of immunosuppressive treatment. Among the 274 patients who disc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0200

    authors: Stewart BL,Storer B,Storek J,Deeg HJ,Storb R,Hansen JA,Appelbaum FR,Carpenter PA,Sanders JE,Kiem HP,Nash RA,Petersdorf EW,Moravec C,Morton AJ,Anasetti C,Flowers ME,Martin PJ

    更新日期:2004-12-01 00:00:00

  • Human mononuclear cells express 12-LX: coordinated mRNA regulation with 5-LX and FLAP genes.

    abstract::Lipoxygenases (LXs) catalyze formation of leukotrienes and hydroxy-eicosatetraenoic acids (HETEs), proinflammatory, and spasmogenic autacoids that are critical for host defense systems. We studied the expression and regulation of LX genes (12-LX, 5-LX, and 15-LX) and the 5-lipoxygenase activating protein (FLAP) in hum...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kaminski WE,Jendraschak E,Baumann K,Kiefl R,Fischer S,Marcus AJ,Broekman MJ,von Schacky C

    更新日期:1996-01-01 00:00:00

  • The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse.

    abstract::Among dendritic cell (DC) subsets, CD8alpha(+) DCs and plasmacytoid DCs (pDCs) produce high levels of IL12 and type I interferons (IFNs), respectively, and confer early innate immunity. Development of CD8alpha(+) DCs and pDCs requires the interferon regulatory factor 8 (IRF8). Recently, a spontaneous point mutation wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-100750

    authors: Tailor P,Tamura T,Morse HC 3rd,Ozato K

    更新日期:2008-02-15 00:00:00

  • The inherited diseases of hemoglobin are an emerging global health burden.

    abstract::It is estimated that in excess of 300,000 children are born each year with a severe inherited disorder of hemoglobin and that approximately 80% of these births occur in low- or middle-income countries. As these countries go through an epidemiologic transition, with a reduction in childhood and infant mortality due to ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-01-251348

    authors: Weatherall DJ

    更新日期:2010-06-03 00:00:00

  • Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

    abstract::Natural killer (NK) cells have held great promise for the immunotherapy of cancer for more than 3 decades. However, to date only modest clinical success has been achieved manipulating the NK cell compartment in patients with malignant disease. Progress in the field of NK cell receptors has revolutionized our concept o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2002-02-0350

    authors: Farag SS,Fehniger TA,Ruggeri L,Velardi A,Caligiuri MA

    更新日期:2002-09-15 00:00:00

  • Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: potential mechanisms for survival enhancing effects.

    abstract::Thrombopoietin (Tpo) has proliferative and maturational effects on immature and more committed cells, respectively. We previously reported a role for Tpo as a survival factor in the factor-dependent human cell line M07e by demonstrating that Tpo suppresses apoptosis in the absence of induced proliferation. Wild-type p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ritchie A,Gotoh A,Gaddy J,Braun SE,Broxmeyer HE

    更新日期:1997-12-01 00:00:00

  • Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver.

    abstract::The cell-surface expression and the functional status of the CD95/Fas antigen on primitive hematopoietic progenitors (PHPs) freshly isolated from human fetal liver (FL) were studied. PHPs were phenotypically defined as CD34++ CD38 -/+ cells. The most immature subfractions of PHPs, CD34++CD38- and CD34+2CD38+ FL cells,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bárcena A,Park SW,Banapour B,Muench MO,Mechetner E

    更新日期:1996-09-15 00:00:00

  • Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.

    abstract::Human T-cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T-cell leukemia (ATL) transforms human T cells both in vivo and in vitro. However, the long latency period between infection and development of ATL, as well as the small fraction of the infected population that actually develops this disease, su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Kashanchi F,Prager D

    更新日期:1997-12-15 00:00:00